TreeWAS – Variant ID: rs10879517

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
Y45.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.036	0.964	0.000
Y45 Analgesics, antipyretics and anti-inflammatory drugs	0.028	0.972	0.000
Y45.0 Opioids and related analgesics	0.028	0.972	0.000
Y45.8 Other analgesics and antipyretics	0.024	0.976	0.000
Y45.4 Antirheumatics	0.020	0.980	0.000
Y45.2 Propionic acid derivatives	0.020	0.980	0.000
M50.3 Other cervical disk degeneration	0.019	0.981	0.000
Y45.9 Analgesic, antipyretic and anti-inflammatory drug, unspecified	0.019	0.981	0.000
Y45.5 4-Aminophenol derivatives	0.018	0.982	0.000
Y45.1 Salicylates	0.015	0.984	0.000
R44.3 Hallucinations, unspecified	0.009	0.991	0.000
Z48.0 Attention to surgical dressings and sutures	0.000	0.991	0.009
K08.3 Retained dental root	0.008	0.992	0.000
D22.0 Melanocytic naevi of lip	0.008	0.992	0.000
Z11.0 Special screening examination for intestinal infectious diseases	0.007	0.993	0.000
K86.1 Other chronic pancreatitis	0.006	0.994	0.000
Z11 Special screening examination for infectious and parasitic diseases	0.005	0.995	0.000
Z11.4 Special screening examination for human immunodeficiency virus [HIV]	0.005	0.995	0.000
C15.5 Lower third of oesophagus	0.000	0.995	0.005
Z11.5 Special screening examination for other viral diseases	0.005	0.995	0.000
Z11.9 Special screening examination for infectious and parasitic diseases, unspecified	0.005	0.995	0.000
K40.2 Bilateral inguinal hernia, without obstruction or gangrene	0.000	0.995	0.005
Z11.1 Special screening examination for respiratory tuberculosis	0.004	0.995	0.000
Z11.6 Special screening examination for other protozoal diseases and helminthiases	0.004	0.996	0.000
Z11.3 Special screening examination for infections with a predominantly sexual mode of transmission	0.004	0.996	0.000
Z11.8 Special screening examination for other infectious and parasitic diseases	0.004	0.996	0.000
O63.0 Prolonged first stage (of labour)	0.004	0.996	0.000
K08.9 Disorder of teeth and supporting structures, unspecified	0.004	0.996	0.000
K08 Other disorders of teeth and supporting structures	0.004	0.996	0.000
H50.2 Vertical strabismus	0.000	0.996	0.004
R44 Other symptoms and signs involving general sensations and perceptions	0.004	0.996	0.000
K08.2 Atrophy of edentulous alveolar ridge	0.003	0.997	0.000
R44.1 Visual hallucinations	0.003	0.997	0.000
M47.80 Other spondylosis (Multiple sites in spine)	0.000	0.997	0.003
D15.1 Heart	0.003	0.997	0.000
X41.9 Unspecified place	0.000	0.997	0.003
M47.86 Other spondylosis (Lumbar region)	0.000	0.997	0.003
R40.0 Somnolence	0.003	0.997	0.000
M50 Cervical disk disorders	0.003	0.997	0.000
C62.9 Testis, unspecified	0.000	0.997	0.003
M47.87 Other spondylosis (Lumbosacral region)	0.000	0.997	0.003
K08.0 Exfoliation of teeth due to systemic causes	0.003	0.997	0.000
M47.8 Other spondylosis	0.000	0.997	0.003
O68.8 Labour and delivery complicated by other evidence of foetal stress	0.000	0.997	0.003
R44.2 Other hallucinations	0.003	0.997	0.000
C15 Malignant neoplasm of oesophagus	0.000	0.997	0.003
R44.8 Other and unspecified symptoms and signs involving general sensations and perceptions	0.003	0.997	0.000
H50.1 Divergent concomitant strabismus	0.000	0.997	0.003
C15.3 Upper third of oesophagus	0.000	0.997	0.003
M50.8 Other cervical disk disorders	0.002	0.997	0.000
X23.9 Unspecified place	0.003	0.997	0.000
H50 Other strabismus	0.000	0.997	0.003
H50.5 Heterophoria	0.000	0.997	0.003
A04.7 Enterocolitis due to Clostridium difficile	0.000	0.997	0.002
M47.82 Other spondylosis (Cervical region)	0.000	0.998	0.002
C15.9 Oesophagus, unspecified	0.000	0.998	0.002
H11.3 Conjunctival haemorrhage	0.002	0.998	0.000
N30.3 Trigonitis	0.002	0.998	0.000
Z11.2 Special screening examination for other bacterial diseases	0.002	0.998	0.000
H11.9 Disorder of conjunctiva, unspecified	0.002	0.998	0.000
M47.85 Other spondylosis (Thoracolumbar region)	0.000	0.998	0.002
M47.83 Other spondylosis (Cervicothoracic region)	0.000	0.998	0.002
M47.81 Other spondylosis (Occipito-atlanto-axial region)	0.000	0.998	0.002
H50.4 Other and unspecified heterotropia	0.000	0.998	0.002
M50.9 Cervical disk disorder, unspecified	0.002	0.998	0.000
I46.9 Cardiac arrest, unspecified	0.000	0.998	0.002
H26.4 After-cataract	0.002	0.998	0.000
T63.4 Venom of other arthropods	0.002	0.998	0.000
M47.84 Other spondylosis (Thoracic region)	0.000	0.998	0.002
C15.8 Overlapping lesion of oesophagus	0.000	0.998	0.002
C15.2 Abdominal part of oesophagus	0.000	0.998	0.002
C15.1 Thoracic part of oesophagus	0.000	0.998	0.002
M47.88 Other spondylosis (Sacral and sacrococcygeal region)	0.000	0.998	0.002
N39.3 Stress incontinence	0.000	0.998	0.002
C15.0 Cervical part of oesophagus	0.000	0.998	0.002
C49.3 Connective and soft tissue of thorax	0.002	0.998	0.000
D70 Agranulocytosis	0.000	0.998	0.002
H50.8 Other specified strabismus	0.000	0.998	0.002
R74.8 Abnormal levels of other serum enzymes	0.002	0.998	0.000
H50.6 Mechanical strabismus	0.000	0.998	0.002
H50.3 Intermittent heterotropia	0.000	0.998	0.002
I77.1 Stricture of artery	0.000	0.998	0.002
S29.9 Unspecified injury of thorax	0.000	0.998	0.002
N61 Inflammatory disorders of breast	0.000	0.998	0.002
I49.8 Other specified cardiac arrhythmias	0.000	0.998	0.002
F81.9 Developmental disorder of scholastic skills, unspecified	0.002	0.998	0.000
M50.0 Cervical disk disorder with myelopathy	0.002	0.998	0.000
Y54.4 Loop [high-ceiling] diuretics	0.002	0.998	0.000
M47.22 Other spondylosis with radiculopathy (Cervical region)	0.000	0.998	0.002
S66.2 Injury of extensor muscle and tendon of thumb at wrist and hand level	0.002	0.998	0.000
C45.0 Mesothelioma of pleura	0.000	0.998	0.002
C49.6 Connective and soft tissue of trunk, unspecified	0.002	0.998	0.000
C49 Malignant neoplasm of other connective and soft tissue	0.002	0.998	0.000
E21.3 Hyperparathyroidism, unspecified	0.000	0.998	0.002
I42.0 Dilated cardiomyopathy	0.000	0.998	0.002
T84.2 Mechanical complication of internal fixation device of other bones	0.002	0.998	0.000
S92.00 Fracture of calcaneus (closed)	0.002	0.998	0.000
C49.1 Connective and soft tissue of upper limb, including shoulder	0.002	0.998	0.000
T87.6 Other and unspecified complications of amputation stump	0.000	0.998	0.002
X23.0 Home	0.002	0.998	0.000
X23 Contact with hornets, wasps and bees	0.002	0.998	0.000
X41 Accidental poisoning by and exposure to antiepileptic, sedative-hypnotic, anti-Parkinsonism and psychotropic drugs, not elsewhere classified	0.000	0.998	0.002
S06.80 Other intracranial injuries (without open intracranial wound)	0.002	0.998	0.000
R06.8 Other and unspecified abnormalities of breathing	0.002	0.998	0.000
S66.0 Injury of long flexor muscle and tendon of thumb at wrist and hand level	0.002	0.998	0.000
I42.2 Other hypertrophic cardiomyopathy	0.000	0.998	0.002
S82.20 Fracture of shaft of tibia (closed)	0.002	0.998	0.000
C49.5 Connective and soft tissue of pelvis	0.002	0.998	0.000
R16.1 Splenomegaly, not elsewhere classified	0.000	0.998	0.002
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]	0.002	0.998	0.000
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism	0.002	0.998	0.000
M13.97 Arthritis, unspecified (Ankle and foot)	0.000	0.998	0.002
M50.2 Other cervical disk displacement	0.002	0.998	0.000
T91.1 Sequelae of fracture of spine	0.002	0.998	0.000
M19.96 Arthrosis, unspecified-Lower leg	0.002	0.998	0.000
C15.4 Middle third of oesophagus	0.000	0.998	0.002
H11 Other disorders of conjunctiva	0.002	0.998	0.000
C49.9 Connective and soft tissue, unspecified	0.002	0.998	0.000
M34.8 Other forms of systemic sclerosis	0.002	0.998	0.000
R44.0 Auditory hallucinations	0.001	0.998	0.000
Y54.5 Other diuretics	0.002	0.998	0.000
Z29.0 Isolation	0.000	0.998	0.002
O16 Unspecified maternal hypertension	0.000	0.998	0.002
C49.2 Connective and soft tissue of lower limb, including hip	0.002	0.998	0.000
C49.0 Connective and soft tissue of head, face and neck	0.002	0.998	0.000
N02.9 Unspecified	0.002	0.998	0.000
T87.4 Infection of amputation stump	0.000	0.998	0.002
Y54.7 Agents affecting calcification	0.002	0.998	0.000
C49.8 Overlapping lesion of connective and soft tissue	0.002	0.998	0.000
H50.9 Strabismus, unspecified	0.000	0.998	0.002
D46.9 Myelodysplastic syndrome, unspecified	0.000	0.998	0.002
Z29.1 Prophylactic immunotherapy	0.000	0.998	0.002
S66 Injury of muscle and tendon at wrist and hand level	0.002	0.998	0.000
K08.1 Loss of teeth due to accident, extraction or local periodontal disease	0.001	0.998	0.000
X23.8 Other specified place	0.001	0.998	0.000
X23.7 Farm	0.001	0.998	0.000
X23.6 Industrial and construction area	0.001	0.998	0.000
X23.5 Trade and service area	0.001	0.998	0.000
X23.4 Street and highway	0.001	0.998	0.000
X23.3 Sports and athletics area	0.001	0.998	0.000
X23.2 School, other institution and public administrative area	0.001	0.998	0.000
X23.1 Residential institution	0.001	0.998	0.000
X41.0 Home	0.000	0.998	0.001
X41.8 Other specified place	0.000	0.998	0.001
X41.7 Farm	0.000	0.998	0.001
X41.6 Industrial and construction area	0.000	0.998	0.001
X41.5 Trade and service area	0.000	0.998	0.001
X41.4 Street and highway	0.000	0.998	0.001
X41.3 Sports and athletics area	0.000	0.998	0.001
X41.2 School, other institution and public administrative area	0.000	0.998	0.001
X41.1 Residential institution	0.000	0.998	0.001
Y43.0 Antiallergic and antiemetic drugs	0.000	0.998	0.002
R46.8 Other symptoms and signs involving appearance and behaviour	0.002	0.998	0.000
M47.89 Other spondylosis (Site unspecified)	0.000	0.998	0.002
H11.8 Other specified disorders of conjunctiva	0.002	0.998	0.000
I42.8 Other cardiomyopathies	0.000	0.998	0.002
K08.8 Other specified disorders of teeth and supporting structures	0.002	0.998	0.000
S66.8 Injury of other muscles and tendons at wrist and hand level	0.002	0.998	0.000
Y43.3 Other antineoplastic drugs	0.000	0.998	0.002
E53.8 Deficiency of other specified B group vitamins	0.002	0.998	0.000
T87.3 Neuroma of amputation stump	0.000	0.998	0.002
C49.4 Connective and soft tissue of abdomen	0.001	0.998	0.000
Y52.4 Angiotensin-converting-enzyme inhibitors	0.000	0.998	0.002
K86 Other diseases of pancreas	0.002	0.998	0.000
S66.1 Injury of flexor muscle and tendon of other finger at wrist and hand level	0.002	0.998	0.000
Y54.9 Mineral salts, not elsewhere classified	0.001	0.998	0.000
Y54.6 Electrolytic, caloric and water-balance agents	0.001	0.998	0.000
Y54.2 Carbonic-anhydrase inhibitors	0.001	0.998	0.000
Y54.0 Mineralocorticoids	0.001	0.998	0.000
Y57.6 Other diagnostic agents	0.002	0.998	0.000
Z29.2 Other prophylactic chemotherapy	0.000	0.998	0.002
A16.9 Respiratory tuberculosis unspecified, without mention of bacteriological or histological confirmation	0.001	0.998	0.000
E13.9 Without complications	0.002	0.998	0.000
G72.9 Myopathy, unspecified	0.000	0.998	0.002
I42.6 Alcoholic cardiomyopathy	0.000	0.998	0.002
T17.2 Foreign body in pharynx	0.000	0.998	0.002
D15 Benign neoplasm of other and unspecified intrathoracic organs	0.002	0.998	0.000
C48.0 Retroperitoneum	0.000	0.998	0.001
Y54.8 Agents affecting uric acid metabolism	0.001	0.998	0.000
M82.11 Osteoporosis in endocrine disorders (Shoulder region)	0.001	0.998	0.000
S66.7 Injury of multiple extensor muscles and tendons at wrist and hand level	0.001	0.998	0.000
T87 Complications peculiar to reattachment and amputation	0.000	0.998	0.002
I42 Cardiomyopathy	0.000	0.998	0.002
B08.1 Molluscum contagiosum	0.000	0.999	0.001
D15.0 Thymus	0.001	0.999	0.000
H90.3 Sensorineural hearing loss, bilateral	0.000	0.999	0.001
O32.1 Maternal care for breech presentation	0.000	0.999	0.001
Z48.8 Other specified surgical follow-up care	0.001	0.999	0.000
S92.01 Fracture of calcaneus (open)	0.001	0.999	0.000
X41.08 Accidental poisoning by and exposure to antiepileptic, sedative-hypnotic, antiparkinsonism and psychotropic drugs, not elsewhere classified , Home ,While engaged in other specified activities	0.000	0.999	0.001
E21.0 Primary hyperparathyroidism	0.000	0.999	0.001
I74.5 Embolism and thrombosis of iliac artery	0.001	0.999	0.000
S66.5 Injury of intrinsic muscle and tendon of other finger at wrist and hand level	0.001	0.999	0.000
S66.4 Injury of intrinsic muscle and tendon of thumb at wrist and hand level	0.001	0.999	0.000
A16.2 Tuberculosis of lung, without mention of bacteriological or histological confirmation	0.001	0.999	0.000
H11.2 Conjunctival scars	0.001	0.999	0.000
S66.9 Injury of unspecified muscle and tendon at wrist and hand level	0.001	0.999	0.000
C17.9 Small intestine, unspecified	0.000	0.999	0.001
D15.9 Intrathoracic organ, unspecified	0.001	0.999	0.000
D15.7 Other specified intrathoracic organs	0.001	0.999	0.000
D15.2 Mediastinum	0.001	0.999	0.000
J84.1 Other interstitial pulmonary diseases with fibrosis	0.001	0.999	0.000
K35.3 Acute appendicitis with localized peritonitis	0.000	0.999	0.001
C45 Mesothelioma	0.000	0.999	0.001
Z29 Need for other prophylactic measures	0.000	0.999	0.001
M54.37 Sciatica (Lumbosacral region)	0.001	0.999	0.000
R25.3 Fasciculation	0.001	0.999	0.000
T14.6 Injury of tendons and muscles of unspecified body region	0.001	0.999	0.000
C45.7 Mesothelioma of other sites	0.000	0.999	0.001
E53.9 Vitamin B deficiency, unspecified	0.001	0.999	0.000
K86.2 Cyst of pancreas	0.001	0.999	0.000
L12.9 Pemphigoid, unspecified	0.001	0.999	0.000
I42.5 Other restrictive cardiomyopathy	0.000	0.999	0.001
I42.4 Endocardial fibroelastosis	0.000	0.999	0.001
I42.3 Endomyocardial (eosinophilic) disease	0.000	0.999	0.001
K25.3 Acute without haemorrhage or perforation	0.001	0.999	0.000
T14.0 Superficial injury of unspecified body region	0.001	0.999	0.000
T87.5 Necrosis of amputation stump	0.000	0.999	0.001
T87.2 Complications of other reattached body part	0.000	0.999	0.001
T87.1 Complications of reattached (part of) lower extremity	0.000	0.999	0.001
T87.0 Complications of reattached (part of) upper extremity	0.000	0.999	0.001
W49.0 Home	0.001	0.999	0.000
S66.3 Injury of extensor muscle and tendon of other finger at wrist and hand level	0.001	0.999	0.000
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system	0.001	0.999	0.000
S22.20 Fracture of sternum (closed)	0.000	0.999	0.001
H11.4 Other conjunctival vascular disorders and cysts	0.001	0.999	0.000
K86.3 Pseudocyst of pancreas	0.001	0.999	0.000
O26.9 Pregnancy-related condition, unspecified	0.000	0.999	0.001
S66.6 Injury of multiple flexor muscles and tendons at wrist and hand level	0.001	0.999	0.000
S92.0 Fracture of calcaneus	0.001	0.999	0.000
Y55.4 Expectorants	0.001	0.999	0.000
H11.0 Pterygium	0.001	0.999	0.000
C62 Malignant neoplasm of testis	0.000	0.999	0.001
R40 Somnolence, stupor and coma	0.001	0.999	0.000
Y57 Other and unspecified drugs and medicaments	0.001	0.999	0.000
K04.5 Chronic apical periodontitis	0.001	0.999	0.000
K90.0 Coeliac disease	0.000	0.999	0.001
L12.0 Bullous pemphigoid	0.001	0.999	0.000
M31.6 Other giant cell arteritis	0.000	0.999	0.001
T81.5 Foreign body accidentally left in body cavity or operation wound following a procedure	0.000	0.999	0.001
Y55.6 Antiasthmatics, not elsewhere classified	0.001	0.999	0.000
Z29.9 Prophylactic measure, unspecified	0.000	0.999	0.001
E21 Hyperparathyroidism and other disorders of parathyroid gland	0.000	0.999	0.001
C21.0 Anus, unspecified	0.000	0.999	0.001
C45.2 Mesothelioma of pericardium	0.000	0.999	0.001
C45.1 Mesothelioma of peritoneum	0.000	0.999	0.001
H50.0 Convergent concomitant strabismus	0.000	0.999	0.001
K86.0 Alcohol-induced chronic pancreatitis	0.001	0.999	0.000
S14.3 Injury of brachial plexus	0.001	0.999	0.000
G31.2 Degeneration of nervous system due to alcohol	0.001	0.999	0.000
I42.7 Cardiomyopathy due to drugs and other external agents	0.000	0.999	0.001
R57.0 Cardiogenic shock	0.001	0.999	0.000
A16 Respiratory tuberculosis, not confirmed bacteriologically or histologically	0.001	0.999	0.000
T14 Injury of unspecified body region	0.001	0.999	0.000
Y46 Antiepileptics and anti-Parkinsonism drugs	0.001	0.999	0.000
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.001	0.999	0.000
C45.9 Mesothelioma, unspecified	0.000	0.999	0.001
D75.1 Secondary polycythaemia	0.001	0.999	0.000
T14.9 Injury, unspecified	0.001	0.999	0.000
Y46.4 Iminostilbenes	0.001	0.999	0.000
Z92.6 Personal history of chemotherapy for neoplastic disease	0.000	0.999	0.001
E53 Deficiency of other B group vitamins	0.001	0.999	0.000
Y43 Primarily systemic agents	0.000	0.999	0.001
K40.3 Unilateral or unspecified inguinal hernia, with obstruction, without gangrene	0.000	0.999	0.001
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.000	0.999	0.001
Y52.2 Other antidysrhythmic drugs, not elsewhere classified	0.000	0.999	0.001
Y55.7 Other and unspecified agents primarily acting on the respiratory system	0.001	0.999	0.000
Y55.5 Anticommon cold drugs	0.001	0.999	0.000
Y55.3 Antitussives	0.001	0.999	0.000
Y55.2 Other and unspecified agents primarily acting on muscles	0.001	0.999	0.000
Y55.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.001	0.999	0.000
Y55.0 Oxytocic drugs	0.001	0.999	0.000
C21.1 Anal canal	0.000	0.999	0.001
C62.0 Undescended testis	0.000	0.999	0.001
H11.1 Conjunctival degenerations and deposits	0.001	0.999	0.000
H93.1 Tinnitus	0.000	0.999	0.001
Y46.2 Hydantoin derivatives	0.001	0.999	0.000
Y51.3 Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified	0.001	0.999	0.000
Y57.7 Vitamins, not elsewhere classified	0.001	0.999	0.000
Y57.4 Pharmaceutical excipients	0.001	0.999	0.000
Y57.3 Alcohol deterrents	0.001	0.999	0.000
Y57.2 Antidotes and chelating agents, not elsewhere classified	0.001	0.999	0.000
Y57.1 Lipotropic drugs	0.001	0.999	0.000
Y57.0 Appetite depressants [anorectics]	0.001	0.999	0.000
E21.4 Other specified disorders of parathyroid gland	0.000	0.999	0.001
E34.9 Endocrine disorder, unspecified	0.001	0.999	0.000
Y51.6 @-Adrenoreceptor antagonists, not elsewhere classified	0.001	0.999	0.000
Y57.9 Drug or medicament, unspecified	0.001	0.999	0.000
M21.37 Wrist or foot drop (acquired) (Ankle and foot)	0.000	0.999	0.001
A16.8 Other respiratory tuberculosis, without mention of bacteriological or histological confirmation	0.001	0.999	0.000
A16.7 Primary respiratory tuberculosis without mention of bacteriological or histological confirmation	0.001	0.999	0.000
A16.5 Tuberculous pleurisy, without mention of bacteriological or histological confirmation	0.001	0.999	0.000
A16.4 Tuberculosis of larynx, trachea and bronchus, without mention of bacteriological or histological confirmation	0.001	0.999	0.000
A16.3 Tuberculosis of intrathoracic lymph nodes, without mention of bacteriological or histological confirmation	0.001	0.999	0.000
A16.1 Tuberculosis of lung, bacteriological and histological examination not done	0.001	0.999	0.000
A16.0 Tuberculosis of lung, bacteriologically and histologically negative	0.001	0.999	0.000
E21.1 Secondary hyperparathyroidism, not elsewhere classified	0.000	0.999	0.001
T14.2 Fracture of unspecified body region	0.001	0.999	0.000
T14.8 Other injuries of unspecified body region	0.001	0.999	0.000
T14.7 Crushing injury and traumatic amputation of unspecified body region	0.001	0.999	0.000
T14.5 Injury of blood vessel(s) of unspecified body region	0.001	0.999	0.000
T14.4 Injury of nerve(s) of unspecified body region	0.001	0.999	0.000
T14.3 Dislocation, sprain and strain of unspecified body region	0.001	0.999	0.000
T14.1 Open wound of unspecified body region	0.001	0.999	0.000
Y46.8 Antispasticity drugs	0.001	0.999	0.000
Y46.7 Anti-Parkinsonism drugs	0.001	0.999	0.000
Y46.5 Valproic acid	0.001	0.999	0.000
Y46.3 Deoxybarbiturates	0.001	0.999	0.000
Y46.1 Oxazolidinediones	0.001	0.999	0.000
Y46.0 Succinimides	0.001	0.999	0.000
T63 Toxic effect of contact with venomous animals	0.001	0.999	0.000
Y59 Other and unspecified vaccines and biological substances	0.001	0.999	0.000
Y58 Bacterial vaccines	0.001	0.999	0.000
Y53 Agents primarily affecting the gastro-intestinal system	0.001	0.999	0.000
Y51 Drugs primarily affecting the autonomic nervous system	0.001	0.999	0.000
Y50 Central nervous system stimulants, not elsewhere classified	0.001	0.999	0.000
Y47 Sedatives, hypnotics and antianxiety drugs	0.001	0.999	0.000
E21.5 Disorder of parathyroid gland, unspecified	0.000	0.999	0.001
E53.1 Pyridoxine deficiency	0.001	0.999	0.000
E53.0 Riboflavin deficiency	0.001	0.999	0.000
I89.8 Other specified non-infective disorders of lymphatic vessels and lymph nodes	0.001	0.999	0.000
M34.0 Progressive systemic sclerosis	0.001	0.999	0.000
Y43.9 Primarily systemic agent, unspecified	0.000	0.999	0.001
Y43.8 Other primarily systemic agents, not elsewhere classified	0.000	0.999	0.001
Y43.6 Enzymes, not elsewhere classified	0.000	0.999	0.001
Y43.5 Acidifying and alkalising agents	0.000	0.999	0.001
Y43.2 Antineoplastic natural products	0.000	0.999	0.001
F81 Specific developmental disorders of scholastic skills	0.001	0.999	0.000
Y52 Agents primarily affecting the cardiovascular system	0.000	0.999	0.001
M47.27 Other spondylosis with radiculopathy (Lumbosacral region)	0.000	0.999	0.001
C84.4 Peripheral T-cell lymphoma	0.001	0.999	0.000
E21.2 Other hyperparathyroidism	0.000	0.999	0.001
H90.1 Conductive hearing loss, unilateral with unrestricted hearing on the contralateral side	0.000	0.999	0.001
K85.9 Acute pancreatitis, unspecified	0.001	0.999	0.000
L12.1 Cicatricial pemphigoid	0.001	0.999	0.000
M50.1 Cervical disk disorder with radiculopathy	0.001	0.999	0.000
R45.0 Nervousness	0.001	0.999	0.000
R46.0 Very low level of personal hygiene	0.001	0.999	0.000
R94.3 Abnormal results of cardiovascular function studies	0.000	0.999	0.001
Y52.1 Calcium-channel blockers	0.000	0.999	0.001
M47.2 Other spondylosis with radiculopathy	0.000	0.999	0.001
R43.0 Anosmia	0.001	0.999	0.000
R90.8 Other abnormal findings on diagnostic imaging of central nervous system	0.000	0.999	0.001
Y46.6 Other and unspecified antiepileptics	0.001	0.999	0.000
Y47.9 Sedative, hypnotic and antianxiety drug, unspecified	0.001	0.999	0.000
Y47.8 Other sedatives, hypnotics and antianxiety drugs	0.001	0.999	0.000
Y47.5 Mixed sedatives and hypnotics, not elsewhere classified	0.001	0.999	0.000
Y47.4 Bromine compounds	0.001	0.999	0.000
Y47.3 Paraldehyde	0.001	0.999	0.000
Y47.2 Chloral derivatives	0.001	0.999	0.000
Y47.0 Barbiturates, not elsewhere classified	0.001	0.999	0.000
T14.21 Fracture of unspecified body region (open)	0.001	0.999	0.000
T14.20 Fracture of unspecified body region (closed)	0.001	0.999	0.000
C17.2 Ileum	0.000	0.999	0.001
C62.1 Descended testis	0.000	0.999	0.001
D48.5 Skin	0.001	0.999	0.000
G31.8 Other specified degenerative diseases of nervous system	0.001	0.999	0.000
T13.9 Unspecified injury of lower limb, level unspecified	0.001	0.999	0.000
T63.9 Toxic effect of contact with unspecified venomous animal	0.001	0.999	0.000
T63.8 Toxic effect of contact with other venomous animals	0.001	0.999	0.000
T63.6 Toxic effect of contact with other marine animals	0.001	0.999	0.000
T63.5 Toxic effect of contact with fish	0.001	0.999	0.000
T63.3 Venom of spider	0.001	0.999	0.000
T63.2 Venom of scorpion	0.001	0.999	0.000
T63.1 Venom of other reptiles	0.001	0.999	0.000
T63.0 Snake venom	0.001	0.999	0.000
Y47.1 Benzodiazepines	0.001	0.999	0.000
Y50.9 Central nervous system stimulant, unspecified	0.001	0.999	0.000
Y50.8 Other central nervous system stimulants	0.001	0.999	0.000
Y50.2 Methylxanthines, not elsewhere classified	0.001	0.999	0.000
Y50.1 Opioid receptor antagonists	0.001	0.999	0.000
Y50.0 Analeptics	0.001	0.999	0.000
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system	0.001	0.999	0.000
Y51.8 Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified	0.001	0.999	0.000
Y51.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.001	0.999	0.000
Y51.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.001	0.999	0.000
Y51.2 Ganglionic blocking drugs, not elsewhere classified	0.001	0.999	0.000
Y51.1 Other parasympathomimetics [cholinergics]	0.001	0.999	0.000
Y51.0 Anticholinesterase agents	0.001	0.999	0.000
Y53.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.001	0.999	0.000
Y53.8 Other agents primarily affecting the gastro-intestinal system	0.001	0.999	0.000
Y53.7 Emetics	0.001	0.999	0.000
Y53.6 Antidiarrhoeal drugs	0.001	0.999	0.000
Y53.5 Digestants	0.001	0.999	0.000
Y53.3 Saline and osmotic laxatives	0.001	0.999	0.000
Y53.2 Stimulant laxatives	0.001	0.999	0.000
Y53.1 Other antacids and anti-gastric-secretion drugs	0.001	0.999	0.000
Y53.0 Histamine H2-receptor antagonists	0.001	0.999	0.000
Y54.3 Benzothiadiazine derivatives	0.001	0.999	0.000
Y58.9 Other and unspecified bacterial vaccines	0.001	0.999	0.000
Y58.8 Mixed bacterial vaccines, except combinations with a pertussis component	0.001	0.999	0.000
Y58.6 Pertussis vaccine, including combinations with a pertussis component	0.001	0.999	0.000
Y58.5 Diphtheria vaccine	0.001	0.999	0.000
Y58.4 Tetanus vaccine	0.001	0.999	0.000
Y58.3 Plague vaccine	0.001	0.999	0.000
Y58.2 Cholera vaccine	0.001	0.999	0.000
Y58.1 Typhoid and paratyphoid vaccine	0.001	0.999	0.000
Y58.0 BCG vaccine	0.001	0.999	0.000
Y59.9 Vaccine or biological substance, unspecified	0.001	0.999	0.000
Y59.8 Other specified vaccines and biological substances	0.001	0.999	0.000
Y59.3 Immunoglobulin	0.001	0.999	0.000
Y59.2 Protozoal vaccines	0.001	0.999	0.000
Y59.1 Rickettsial vaccines	0.001	0.999	0.000
Y59.0 Viral vaccines	0.001	0.999	0.000
L12 Pemphigoid	0.001	0.999	0.000
R46 Symptoms and signs involving appearance and behaviour	0.001	0.999	0.000
F81.8 Other developmental disorders of scholastic skills	0.001	0.999	0.000
F81.3 Mixed disorder of scholastic skills	0.001	0.999	0.000
F81.2 Specific disorder of arithmetical skills	0.001	0.999	0.000
F81.1 Specific spelling disorder	0.001	0.999	0.000
F81.0 Specific reading disorder	0.001	0.999	0.000
H90.8 Mixed conductive and sensorineural hearing loss, unspecified	0.000	0.999	0.001
I49.0 Ventricular fibrillation and flutter	0.000	0.999	0.001
J17.2 Pneumonia in mycoses	0.000	0.999	0.001
K05.3 Chronic periodontitis	0.000	0.999	0.001
M34.1 CR(E)ST syndrome	0.001	0.999	0.000
R40.1 Stupor	0.001	0.999	0.000
R46.4 Slowness and poor responsiveness	0.000	0.999	0.001
Y52.8 Antivaricose drugs, including sclerosing agents	0.000	0.999	0.001
Y52.7 Peripheral vasodilators	0.000	0.999	0.001
K40 Inguinal hernia	0.000	0.999	0.001
M47.29 Other spondylosis with radiculopathy (Site unspecified)	0.000	0.999	0.001
M47.28 Other spondylosis with radiculopathy (Sacral and sacrococcygeal region)	0.000	0.999	0.001
M47.25 Other spondylosis with radiculopathy (Thoracolumbar region)	0.000	0.999	0.001
M47.24 Other spondylosis with radiculopathy (Thoracic region)	0.000	0.999	0.001
M47.23 Other spondylosis with radiculopathy (Cervicothoracic region)	0.000	0.999	0.001
M47.21 Other spondylosis with radiculopathy (Occipito-atlanto-axial region)	0.000	0.999	0.001
C53.9 Cervix uteri, unspecified	0.000	0.999	0.001
R46.7 Verbosity and circumstantial detail obscuring reason for contact	0.001	0.999	0.000
R46.6 Undue concern and preoccupation with stressful events	0.001	0.999	0.000
R46.5 Suspiciousness and marked evasiveness	0.001	0.999	0.000
R46.3 Overactivity	0.001	0.999	0.000
R46.1 Bizarre personal appearance	0.001	0.999	0.000
Y52.0 Cardiac-stimulant glycosides and drugs of similar action	0.000	0.999	0.001
Y53.4 Other laxatives	0.001	0.999	0.000
Y57.8 Other drugs and medicaments	0.001	0.999	0.000
M23.80 Other internal derangements of knee (Multiple sites)	0.001	0.999	0.000
S92.50 Fracture of other toe (closed)	0.000	0.999	0.001
D64.8 Other specified anaemias	0.001	0.999	0.000
L12.8 Other pemphigoid	0.001	0.999	0.000
L12.3 Acquired epidermolysis bullosa	0.001	0.999	0.000
L12.2 Chronic bullous disease of childhood	0.001	0.999	0.000
N75.1 Abscess of Bartholin's gland	0.000	0.999	0.001
Z41.1 Other plastic surgery for unacceptable cosmetic appearance	0.000	0.999	0.001
M34 Systemic sclerosis	0.001	0.999	0.000
Y48 Anaesthetics and therapeutic gases	0.001	0.999	0.000
H59.8 Other postprocedural disorders of eye and adnexa	0.000	0.999	0.001
K40.4 Unilateral or unspecified inguinal hernia, with gangrene	0.000	0.999	0.001
K40.1 Bilateral inguinal hernia, with gangrene	0.000	0.999	0.001
L93.0 Discoid lupus erythematosus	0.000	0.999	0.001
O68.9 Labour and delivery complicated by foetal stress, unspecified	0.000	0.999	0.001
R43.1 Parosmia	0.001	0.999	0.000
Y43.1 Antineoplastic antimetabolites	0.000	0.999	0.001
Y48.2 Other and unspecified general anaesthetics	0.001	0.999	0.000
Y52.3 Coronary vasodilators, not elsewhere classified	0.000	0.999	0.001
C48 Malignant neoplasm of retroperitoneum and peritoneum	0.000	0.999	0.001
M62.55 Muscle wasting and atrophy, not elsewhere classified (Pelvic region and thigh)	0.001	0.999	0.000
M62.66 Muscle strain (Lower leg)	0.001	0.999	0.000
M82.10 Osteoporosis in endocrine disorders (Multiple sites)	0.001	0.999	0.000
D84.8 Other specified immunodeficiencies	0.001	0.999	0.000
D86.1 Sarcoidosis of lymph nodes	0.001	0.999	0.000
K86.8 Other specified diseases of pancreas	0.001	0.999	0.000
M34.2 Systemic sclerosis induced by drugs and chemicals	0.001	0.999	0.000
M82.1 Osteoporosis in endocrine disorders	0.001	0.999	0.000
T79.8 Other early complications of trauma	0.001	0.999	0.000
Y48.5 Therapeutic gases	0.001	0.999	0.000
Y48.4 Anaesthetic, unspecified	0.001	0.999	0.000
Y48.1 Parenteral anaesthetics	0.001	0.999	0.000
Y48.0 Inhaled anaesthetics	0.001	0.999	0.000
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system	0.000	0.999	0.001
S29 Other and unspecified injuries of thorax	0.000	0.999	0.001
M82.19 Osteoporosis in endocrine disorders (Site unspecified)	0.001	0.999	0.000
M82.18 Osteoporosis in endocrine disorders (Other)	0.001	0.999	0.000
M82.17 Osteoporosis in endocrine disorders (Ankle and foot)	0.001	0.999	0.000
M82.16 Osteoporosis in endocrine disorders (Lower leg)	0.001	0.999	0.000
M82.15 Osteoporosis in endocrine disorders (Pelvic region and thigh)	0.001	0.999	0.000
M82.14 Osteoporosis in endocrine disorders (Hand)	0.001	0.999	0.000
M82.13 Osteoporosis in endocrine disorders (Forearm)	0.001	0.999	0.000
M82.12 Osteoporosis in endocrine disorders (Upper arm)	0.001	0.999	0.000
C48.8 Overlapping lesion of retroperitoneum and peritoneum	0.000	0.999	0.001
E61.1 Iron deficiency	0.001	0.999	0.000
I25.5 Ischaemic cardiomyopathy	0.000	0.999	0.001
I42.1 Obstructive hypertrophic cardiomyopathy	0.000	0.999	0.001
K86.9 Disease of pancreas, unspecified	0.001	0.999	0.000
O72.0 Third-stage haemorrhage	0.000	0.999	0.001
S29.8 Other specified injuries of thorax	0.000	0.999	0.001
S29.7 Multiple injuries of thorax	0.000	0.999	0.001
S29.0 Injury of muscle and tendon at thorax level	0.000	0.999	0.001
T79.7 Traumatic subcutaneous emphysema	0.001	0.999	0.000
Z08.1 Follow-up examination after radiotherapy for malignant neoplasm	0.000	0.999	0.001
Z95.0 Presence of cardiac pacemaker	0.000	0.999	0.001
M43.86 Other specified deforming dorsopathies (Lumbar region)	0.001	0.999	0.000
M47.20 Other spondylosis with radiculopathy (Multiple sites in spine)	0.000	0.999	0.001
C83.0 Small cell (diffuse)	0.001	0.999	0.000
K25.0 Acute with haemorrhage	0.001	0.999	0.000
Y57.5 X-ray contrast media	0.001	0.999	0.000
H90 Conductive and sensorineural hearing loss	0.000	0.999	0.001
R43 Disturbances of smell and taste	0.001	0.999	0.000
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs	0.001	0.999	0.000
C13.9 Hypopharynx, unspecified	0.001	0.999	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations